These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21375726)

  • 1. Alternative TFAP2A isoforms have distinct activities in breast cancer.
    Berlato C; Chan KV; Price AM; Canosa M; Scibetta AG; Hurst HC
    Breast Cancer Res; 2011 Mar; 13(2):R23. PubMed ID: 21375726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
    Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
    Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expressions of AP-2α splice variants in pancreatic cancer.
    Carrière C; Mirocha S; Deharvengt S; Gunn JR; Korc M
    Pancreas; 2011 Jul; 40(5):695-700. PubMed ID: 21654541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
    Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
    Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.
    Powe DG; Akhtar G; Habashy HO; Abdel-Fatah T; Rakha EA; Green AR; Ellis IO
    Breast Cancer Res; 2009; 11(6):R90. PubMed ID: 20025767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
    Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
    J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.
    Thewes V; Orso F; Jäger R; Eckert D; Schäfer S; Kirfel G; Garbe S; Taverna D; Schorle H
    BMC Cancer; 2010 May; 10():192. PubMed ID: 20459791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene.
    Limesand SW; Anthony RV
    Eur J Biochem; 2001 Apr; 268(8):2390-401. PubMed ID: 11298758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation pathway is required to maintain the basal breast cancer subtype.
    Bogachek MV; Chen Y; Kulak MV; Woodfield GW; Cyr AR; Park JM; Spanheimer PM; Li Y; Li T; Weigel RJ
    Cancer Cell; 2014 Jun; 25(6):748-61. PubMed ID: 24835590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
    Mitchell DC; Abdelrahim M; Weng J; Stafford LJ; Safe S; Bar-Eli M; Liu M
    J Biol Chem; 2006 Jan; 281(1):51-8. PubMed ID: 16260418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.
    Li M; Wang Y; Hung MC; Kannan P
    Int J Cancer; 2006 Feb; 118(4):802-11. PubMed ID: 16108032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
    Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
    J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer.
    Beck AC; Cho E; White JR; Paemka L; Li T; Gu VW; Thompson DT; Koch KE; Franke C; Gosse M; Wu VT; Landers SR; Pamatmat AJ; Kulak MV; Weigel RJ
    Mol Cancer Res; 2021 Jul; 19(7):1156-1167. PubMed ID: 33753551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of zebrafish melanophores depends on transcription factors AP2 alpha and AP2 epsilon.
    Van Otterloo E; Li W; Bonde G; Day KM; Hsu MY; Cornell RA
    PLoS Genet; 2010 Sep; 6(9):e1001122. PubMed ID: 20862309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
    Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
    DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2.
    Bragança J; Eloranta JJ; Bamforth SD; Ibbitt JC; Hurst HC; Bhattacharya S
    J Biol Chem; 2003 May; 278(18):16021-9. PubMed ID: 12586840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.